Literature DB >> 25803385

Ischaemic Priapism and Glucose-6-Phosphate Dehydrogenase Deficiency: A Mechanism of Increased Oxidative Stress?

B F Morrison1, E B Thompson2, S D Shah2, G H Wharfe3.   

Abstract

Ischaemic priapism is a devastating urological condition that has the potential to cause permanent erectile dysfunction. The disorder has been associated with numerous medical conditions and the use of pharmacotherapeutic agents. The aetiology is idiopathic in a number of cases. There are two prior case reports of the association of ischaemic priapism and glucose-6-phosphate dehydrogenase (G6PD) deficiency. We report on a third case of priapism associated with G6PD deficiency and review recently described molecular mechanisms of increased oxidative stress in the pathophysiology of ischaemic priapism. The case report of a 32-year old Afro-Caribbean male with his first episode of major ischaemic priapism is described. Screening for common causes of ischaemic priapism, including sickle cell disease was negative. Glucose-6-phosphate dehydrogenase deficiency was discovered on evaluation for priapism. Penile aspiration was performed and erectile function was good post treatment.Glucose-6-phosphate dehydrogenase deficiency is a cause for ischaemic priapism and should be a part of the screening process in idiopathic causes of the disorder. Increased oxidative stress occurs in G6PD deficiency and may lead to priapism.

Entities:  

Year:  2014        PMID: 25803385      PMCID: PMC4663963          DOI: 10.7727/wimj.2013.294

Source DB:  PubMed          Journal:  West Indian Med J        ISSN: 0043-3144            Impact factor:   0.171


  12 in total

1.  American Urological Association guideline on the management of priapism.

Authors:  Drogo K Montague; Jonathan Jarow; Gregory A Broderick; Roger R Dmochowski; Jeremy P W Heaton; Tom F Lue; Ajay Nehra; Ira D Sharlip
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

2.  Epidemiology of neonatal jaundice at the University Hospital of the West Indies.

Authors:  C Henny-Harry; H Trotman
Journal:  West Indian Med J       Date:  2012-01       Impact factor: 0.171

Review 3.  Glucose-6-phosphate dehydrogenase, NADPH, and cell survival.

Authors:  Robert C Stanton
Journal:  IUBMB Life       Date:  2012-03-20       Impact factor: 3.885

4.  Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism.

Authors:  Hunter C Champion; Trinity J Bivalacqua; Eiki Takimoto; David A Kass; Arthur L Burnett
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-24       Impact factor: 11.205

5.  Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group.

Authors: 
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

Review 6.  Nitric oxide/redox-based signalling as a therapeutic target for penile disorders.

Authors:  Arthur L Burnett; Biljana Musicki; Liming Jin; Trinity J Bivalacqua
Journal:  Expert Opin Ther Targets       Date:  2006-06       Impact factor: 6.902

7.  Glucose-6-phosphate dehydrogenase deficiency associated stuttering priapism: report of a case.

Authors:  David S Finley
Journal:  J Sex Med       Date:  2008-09-24       Impact factor: 3.802

8.  Glucose-6-phosphate dehydrogenase deficiency: an etiology for idiopathic priapism?

Authors:  Arthur L Burnett; Trinity J Bivalacqua
Journal:  J Sex Med       Date:  2007-10-25       Impact factor: 3.802

9.  Priapism and impotence in homozygous sickle cell disease.

Authors:  A M Emond; R Holman; R J Hayes; G R Serjeant
Journal:  Arch Intern Med       Date:  1980-11

10.  Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue.

Authors:  N D Kanika; A Melman; K P Davies
Journal:  Int J Impot Res       Date:  2010-11-18       Impact factor: 2.896

View more
  1 in total

1.  Coupling between Protein Stability and Catalytic Activity Determines Pathogenicity of G6PD Variants.

Authors:  Anna D Cunningham; Alexandre Colavin; Kerwyn Casey Huang; Daria Mochly-Rosen
Journal:  Cell Rep       Date:  2017-03-14       Impact factor: 9.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.